Fibroblast Growth Factor 21 (FGF21) is assumed to beone of the most promising candidates for obesity treatment,because administration of FGF21 or its analogs was shownto reduce body weight in laboratory rodents, monkeys, andhumans (Jackson et al., 2015). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.